Skip to main content
News Icon

Cluster goes Charity

Cluster goes Charity!

All of our cluster member were invited to collect bootle caps, which have have a certain amount of recyclable materials which can be reused.

Similar to gold this resource will be recycled and the earnings will be donated to the FÖRDERKREIS BONN E.V..
For more than 35 years, the Förderkreis Bonn e.V. has been at the side of young
patients of the oncology ward of the University Children’s Hospital Bonn. From overnight accommodation close to the clinic for parents, games, handicrafts, workshops or holiday periods for patients and their siblings, psycho-oncological and psychosocial counselling, palliative care to support for the paediatric oncology ward. (More information: https://www.foerderkreis-bonn.de/helfen/kronkorken-aktion/)

We want to say - Thank you! - to all our members who donated such a massive amount of bottle caps.

We are still happy to receive any bottle cap in our office located in the basement of BMZI.

Related news

Kathrin Leppek Publication PM

News categories: Publication

Starting points for the control of protein synthesis

Bonn researchers develop a versatile toolbox for the characterization of IRESes in cells.
View entry
Pandyra Publication Graphical Abstract

News categories: Publication

Genetic mutation affects survival after viral infection

Scientists discovered that haploinsufficiency in the Pax5 gene affects antiviral responses. The study was led by Prof. Dr. Aleksandra Pandyra from the Institute of Clinical Chemistry and Clinical Pharmacology at the University Hospital Bonn in collaboration with Prof. Dr. Arndt Borkhardt, Clinic Director at the Pediatric Oncology at the University Hospital Düsseldorf. The findings were published in the latest edition of EMBO Molecular Medicine.
View entry
Reckzeh News

News categories: Honors & Funding

Creating Personalized Cancer Treatments

Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry

Back to the news overview